Anti-Human TGFB1 Therapeutic Antibody (LY2382770)
Recombinant Humanized monoclonal antibody expressed in CHO binding to Human TGFB1. LY 2382770 is a monoclonal antibody inhibitor of transforming growth factor-beta (TGF-β) kinase, for the treatment of kidney disease due to diabetes.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-605CL |
| Pricing | Inquiry |
| Type | Antibody |
| Storage | ≤1 year at -20°C. |
| Target | TGFB1 |
| Species Reactivity | Human |